Cancer
Conditions
Brief summary
CareSignal has developed an application that allows for remote collection of patient-reported data such as symptoms or outcomes on any device compatible with the short message service (SMS), otherwise known as text messaging. The software can be configured to complete symptom monitoring by surveying patients about toxicity using the PRO-CTCAE tools. PRO-CTCAE is the patient reported outcomes version of the CTCAE that was designed by the National Cancer Institute (NCI) for use in clinical trials.
Interventions
OTHERCareSignal
The CareSignal software will be programmed to automatically ask a subset of the NCI-PRO-CTCAE questions using SMS depending on patient group as designated by the treating physician: (1) thoracic radiation with chemotherapy, (2) thoracic radiation alone, (3) extremity/body wall sarcoma, and (4) other.
Sponsors
Washington University School of Medicine
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Currently planning to receive radiotherapy for 2 or more fractions with or without chemotherapy. * Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable). * Age 18 years or older.
Exclusion criteria
-Unable to reliably access and use a device compatible with CareSignal software.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of invited symptom reports completed during the study period | From treatment through 30 days follow-up (estimated to be 3 months) |
| Percentage of questions completed within each invited symptom report | From treatment through 30 days follow-up (estimated to be 3 months) |
Countries
United States
Outcome results
None listed